Stem Cell Medical Reports for: Optic Nerve Atrophy
Author or authors of report : Rosa M. Coco-Martin, Salvador Pastor-Idoate, Jose Carlos Pastor, Yolanda Diebold, and Laura García-Posadas
Date of report : 2021-06-11
Optic Nerve Atrophy
Major Points and Findings: Objective: The review aimed to provide an update on the potential of cell therapies to restore or replace damaged and/or lost cells in retinal degenerative and
Author or authors of report : Ben Mead, Martin Berry, Ann Logan, Robert A.H. Scott, Wendy Leadbeater, Ben A. Scheven
Date of report : 2015-05-14
Optic Nerve Atrophy
Abstract: Stem cell therapies are being researched extensively for treating degenerative eye diseases. These therapies aim to replace lost neurons, restore neural circuits, or provide paracrine-mediated therapies where stem cell-derived
Author or authors of report : Parker E. Ludwig, S. Caleb Freeman, Adam C. Janot.
Date of report : 2019-02-13
Optic Nerve Atrophy
Major Points and Findings: Introduction and Background: Degenerative retinal diseases, such as diabetic retinopathy and macular degeneration, are leading causes of blindness in the developed world. Current therapies can slow
Author or authors of report : Sonia Labrador-Velandia, María Luz Alonso-Alonso, Sara Alvarez-Sanchez, Jorge González-Zamora, Irene Carretero-Barrio, José Carlos Pastor, Iván Fernandez-Bueno, and Girish Kumar Srivastava
Date of report : 2016-11-26
Optic Nerve Atrophy
The medical report titled "Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials" focuses on the potential of mesenchymal stem cells (MSCs) in treating
Author or authors of report : Neil M Bressler, Jennifer Arnold, Mustapha Benchaboune, Mark S Blumenkranz, Gary E Fish, Evangelos S Gragoudas, Hilel Lewis, Ursula Schmidt-Erfurth, Jason S Slakter, Susan B Bressler, Kelly Manos, Yong Hao, Laurie Hayes, John Koester, Al Reaves, H Andrew
Date of report : 2002-11-01
Optic Nerve Atrophy
Objective and Methods: The study aimed to explore the influence of baseline lesion composition on vision outcomes in patients with AMD treated with verteporfin for subfoveal choroidal neovascularization (CNV). Patients
Author or authors of report : Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Jr, Ingrid U. Scott,
Date of report : 2012-02-28
Optic Nerve Atrophy
Major Points: Introduction to AMD: Age-related macular degeneration is a complex condition involving interactions between various biological factors that can lead to choroidal neovascularization (CNV). VEGF plays a crucial role
Author or authors of report : Christine A. DeWitt, Lenworth N. Johnson, Dana B. Schoenleber, Dean P. Hainsworth, and Richard W. Madsen
Date of report : 2003-05-01
Optic Nerve Atrophy
Abstract Summary: This research is a cross-sectional study that aimed to understand the relationship between the degree of optic nerve pallor, also known as optic atrophy, and visual function. The
Author or authors of report : Syed Shoeb Ahmad; Venkata M. Kanukollu.
Date of report : 2022-08-08
Optic Nerve Atrophy
Definition Optic atrophy is the hallmark of damage to the visual pathway, appearing as a pale disc on fundus examination. It is not a disease in itself but indicates damage